ZA200005923B - Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives. - Google Patents

Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives.

Info

Publication number
ZA200005923B
ZA200005923B ZA200005923A ZA200005923A ZA200005923B ZA 200005923 B ZA200005923 B ZA 200005923B ZA 200005923 A ZA200005923 A ZA 200005923A ZA 200005923 A ZA200005923 A ZA 200005923A ZA 200005923 B ZA200005923 B ZA 200005923B
Authority
ZA
South Africa
Prior art keywords
antibacterial agents
enhancement
oxazolidinone antibacterial
arginine derivatives
agents activity
Prior art date
Application number
ZA200005923A
Other languages
English (en)
Inventor
Michael John Bohanon
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of ZA200005923B publication Critical patent/ZA200005923B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200005923A 1998-05-18 2000-10-23 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives. ZA200005923B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8116498A 1998-05-18 1998-05-18

Publications (1)

Publication Number Publication Date
ZA200005923B true ZA200005923B (en) 2001-10-23

Family

ID=22162494

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005923A ZA200005923B (en) 1998-05-18 2000-10-23 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives.

Country Status (25)

Country Link
US (1) US6251869B1 (zh)
EP (1) EP1077718B1 (zh)
JP (1) JP2002515450A (zh)
KR (1) KR20010043695A (zh)
CN (1) CN1170584C (zh)
AT (1) ATE222115T1 (zh)
AU (1) AU746606B2 (zh)
BR (1) BR9910443A (zh)
CA (1) CA2327100A1 (zh)
CZ (1) CZ291945B6 (zh)
DE (1) DE69902526T2 (zh)
DK (1) DK1077718T3 (zh)
EA (1) EA003458B1 (zh)
ES (1) ES2182521T3 (zh)
HK (1) HK1036222A1 (zh)
HU (1) HUP0101958A3 (zh)
IL (1) IL139437A0 (zh)
NO (1) NO20005813L (zh)
NZ (1) NZ508256A (zh)
PL (1) PL344049A1 (zh)
PT (1) PT1077718E (zh)
SK (1) SK283038B6 (zh)
TR (1) TR200003384T2 (zh)
WO (1) WO1999059616A1 (zh)
ZA (1) ZA200005923B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US20050255538A1 (en) * 2002-03-15 2005-11-17 Buxser Stephen E Methods for screening for AcrAB efflux pump inhibitors
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
TW200607492A (en) * 2004-06-30 2006-03-01 Novartis Ag Method for increasing the susceptibility of peptide deformylase inhibitors by using efflux pump inhibitors
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
PL1934208T3 (pl) 2005-10-04 2011-09-30 Bayer Ip Gmbh Nowa polimorficzna postać 5-chloro-N-({ (5S)-2-okso-3-[4-( 3-okso-4-morfolinylo)-fenylo]-1,3-oksazolidyn-5-ylo}-metylo)-2-tiofenokarboksamidu
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
JP2017529393A (ja) 2014-09-12 2017-10-05 アンティバイオティクス エーピーエスＡｎｔｉｂｉｏｔｘ Ａｐｓ ハロゲン化サリチルアニリドの抗菌用途
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
CN1211384C (zh) * 1997-07-11 2005-07-20 法玛西雅厄普约翰美国公司 噻二唑基和噁二唑基苯基噁唑烷酮抗菌剂
US6068972A (en) * 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

Also Published As

Publication number Publication date
CN1170584C (zh) 2004-10-13
BR9910443A (pt) 2001-01-02
EP1077718B1 (en) 2002-08-14
PL344049A1 (en) 2001-09-24
CZ20004259A3 (en) 2001-05-16
DE69902526D1 (de) 2002-09-19
EP1077718A1 (en) 2001-02-28
ES2182521T3 (es) 2003-03-01
AU3860199A (en) 1999-12-06
EA003458B1 (ru) 2003-06-26
US6251869B1 (en) 2001-06-26
CZ291945B6 (cs) 2003-06-18
HUP0101958A3 (en) 2003-07-28
ATE222115T1 (de) 2002-08-15
TR200003384T2 (tr) 2001-03-21
NO20005813D0 (no) 2000-11-17
KR20010043695A (ko) 2001-05-25
HUP0101958A2 (hu) 2001-10-28
DK1077718T3 (da) 2002-11-11
CA2327100A1 (en) 1999-11-25
PT1077718E (pt) 2002-12-31
SK16252000A3 (sk) 2001-06-11
NO20005813L (no) 2000-11-17
EA200001197A1 (ru) 2001-04-23
DE69902526T2 (de) 2003-04-03
HK1036222A1 (en) 2001-12-28
SK283038B6 (sk) 2003-02-04
CN1297355A (zh) 2001-05-30
NZ508256A (en) 2003-08-29
WO1999059616A1 (en) 1999-11-25
JP2002515450A (ja) 2002-05-28
IL139437A0 (en) 2001-11-25
AU746606B2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
PL344049A1 (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
FI963232A (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
NO20042271L (no) Formuleringer som inneholder en cefalosporinforbindelse og deres anvendelse for behandling av bakterielle infeksjoner i katter og hunder
AP2003002824A0 (en) Gyrase inhibitors and uses thereof
EP1037650A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
ATE433963T1 (de) Fab-i inhibitoren
MX9703634A (es) Derivados de dibencimidazol antibacterianos.
DE60318826D1 (de) Alkoxypyridinderivate
DE69615155T2 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
IL140768A0 (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
EA200501830A1 (ru) Новые производные линкомицина, обладающие антимикробной активностью